{"protocolSection":{"identificationModule":{"nctId":"NCT02377349","orgStudyIdInfo":{"id":"116945"},"secondaryIdInfos":[{"id":"2014-001119-38","type":"EUDRACT_NUMBER"},{"id":"2014","type":"NIH","link":"https://reporter.nih.gov/quickSearch/2014"}],"organization":{"fullName":"GlaxoSmithKline","class":"INDUSTRY"},"briefTitle":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women","officialTitle":"Immunogenicity and Safety Study of GSK Biologicals' dTpa Vaccine, Boostrix™ (263855) in Pregnant Women"},"statusModule":{"statusVerifiedDate":"2020-01","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2015-10-14","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2017-08-14","type":"ACTUAL"},"completionDateStruct":{"date":"2017-10-24","type":"ACTUAL"},"studyFirstSubmitDate":"2015-02-26","studyFirstSubmitQcDate":"2015-02-26","studyFirstPostDateStruct":{"date":"2015-03-03","type":"ESTIMATED"},"resultsFirstSubmitDate":"2018-08-10","resultsFirstSubmitQcDate":"2018-08-10","resultsFirstPostDateStruct":{"date":"2019-01-28","type":"ACTUAL"},"lastUpdateSubmitDate":"2020-01-16","lastUpdatePostDateStruct":{"date":"2020-01-28","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"GlaxoSmithKline","class":"INDUSTRY"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The purpose of this study is to assess the immunogenicity and safety of Boostrix™ when compared to a placebo given during 27-36 weeks of gestation in healthy women aged 18-45 years. Infants born to mothers enrolled in this study will be followed-up in two separate clinical studies: 201330 \\[DTPA (BOOSTRIX)-048 PRI\\] and 201334 \\[DTPA (BOOSTRIX)-049 BST: 048\\].","detailedDescription":"The protocol was amended to include Spain in the study. The reasons for the Spain-specific amendment are listed below:\n\n* Based on the feedback from the Spanish Ethics Committee, the evaluation related to the acceptance of cocooning was added in the protocol.\n* The objectives and endpoints to include cocooning were added in the protocol.\n* The eligibility criteria for participation of household contacts were defined in the protocol.\n* The study procedures for household contacts were included."},"conditionsModule":{"conditions":["Diphtheria-Tetanus-acellular Pertussis Vaccines"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE4"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"CROSSOVER","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"TRIPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":688,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"dTpa Group","type":"EXPERIMENTAL","description":"This group will consist of pregnant women who will receive a single dose of Boostrix™ at 27-36 weeks (i.e. completed 27 weeks until 36 weeks) of gestation (Visit 1) and will receive a dose of the placebo post-delivery (within 72 hours).","interventionNames":["Biological: Boostrix™","Drug: Saline placebo"]},{"label":"Control Group","type":"PLACEBO_COMPARATOR","description":"This group will consist of pregnant women who will receive a single dose of placebo at 27-36 weeks (i.e. completed 27 weeks until 36 weeks) of gestation (Visit 1) and will receive a dose of Boostrix™ post-delivery (within 72 hours).","interventionNames":["Biological: Boostrix™","Drug: Saline placebo"]}],"interventions":[{"type":"BIOLOGICAL","name":"Boostrix™","description":"One dose administered intramuscularly in the deltoid muscle of the non-dominant arm.","armGroupLabels":["Control Group","dTpa Group"]},{"type":"DRUG","name":"Saline placebo","description":"One dose administered intramuscularly in the deltoid muscle of the non-dominant arm.","armGroupLabels":["Control Group","dTpa Group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Antibody Concentrations Against Pertussis Toxoid Antigen (Anti-PT), Filamentous Haemagglutinin Antigen (Anti-FHA) and Pertactin Antigen (Anti-PRN) in Cord Blood Samples","description":"Antibody concentrations were assessed by Enzyme-linked immunosorbent assay (ELISA), tabulated as Geometric Mean Concentrations (GMCs) and expressed in International units per mililiter (IU/mL) for the following assay cut-offs: 2.693 IU/mL for anti-PT, 2.046 IU/mL for anti-FHA and 2.187 IU/mL for anti-PRN.","timeFrame":"At delivery - Visit 3 (anytime after 28 weeks of gestation)"}],"secondaryOutcomes":[{"measure":"Percentage of Subjects by Pregnancy Outcomes","description":"Pregnancy outcomes included live birth with no congenital anomalies, live birth with congenital anomalies, still birth with no congenital anomalies, still birth with congenital anomalies, elective termination with no congenital anomalies and elective termination with congenital anomalies. No subjects with still birth or elective termination of infant were reported.","timeFrame":"From Day 0 (Visit 1) to Month 2 (Visit 4, end of the study)."},{"measure":"Percentage of Subjects With Listed Pregnancy/Neonate Related Adverse Events of Interest","description":"Listed pregnancy-related adverse events of interest/ neonate-related events of interest included gestational diabetes, pregnancy-related hypertension, premature rupture of mem-branes, preterm premature rupture of membranes, premature labour, premature uterine contractions, intrauterine growth restriction/poor foetal growth, pre-eclampsia, eclampsia, vaginal or intrauterine haemorrhage, maternal death, preterm birth, neonatal death, small for gestational age, neonatal hypoxic ischaemic encephalopathy and failure to thrive/growth deficiency were reported.","timeFrame":"From Day 0 (Visit 1) to Month 2 post-delivery (Visit 4, end of the study)."},{"measure":"Percentage of Seroprotected Subjects Against Diphteria Antigen (Anti-D), Tetanus Antigen (Anti-T) and of Seropositive Subjects Against Anti-PT, Anti-FHA and Anti-PRN","description":"A seroprotected subject against diphteria and tetanus was a subject with antibody concentration ≥ 0.1 IU/mL. A seropositive subject was a subjects with antibody concentration ≥ 2.693 IU/mL for anti-PT, ≥ 2.046 IU/mL for anti-FHA and ≥ 2.187 IU/mL for anti-PRN.","timeFrame":"One month post vaccination (Day 30) during pregnancy"},{"measure":"Anti-D, Anti-T, Anti-PT, Anti-FHA and Anti-PRN Antibody Concentrations","description":"Antibody concentrations were determined by ELISA, tabulated as GMCs and expressed in IU/mL.","timeFrame":"One month post vaccination (Day 30) during pregnancy"},{"measure":"Percentage of Subjects With Vaccine Response to Anti-D and Anti-T","description":"Vaccine response for anti-D and anti-T was defined as:\n\nfor initially seronegative subjects (S-) with pre-vaccination concentration below cut-off: \\< 0.1 IU/mL) was an antibody concentration at least four times the assay cut-off (post-vaccination concentration ≥ 0.4 IU/mL); for initially seropositive subjects (S+) with pre-vaccination concentration ≥ 0.1 IU/mL): an increase in antibody concentrations of at least four times the pre-vaccination concentration.","timeFrame":"One month post vaccination (Day 30) during pregnancy"},{"measure":"Percentage of Subjects With Vaccine Response to Anti-PT, Anti-FHA and Anti-PRN","description":"Vaccine response to PT, FHA and PRN antigens is defined as: for subjects with pre-vaccination antibody concentration below the assay cut-off (S-), post-vaccination anti-body concentration ≥ 4 times the assay cut-off; for subjects with pre-vaccination antibody concentration between the assay cut-off and below 4 times the assay cut-off (S+), post-vaccination antibody concentration ≥ 4 times the pre-vaccination antibody concentration, and for subjects with pre-vaccination antibody concentration ≥4 times the assay cut-off (S+), post-vaccination antibody concentration ≥2 times the pre-vaccination antibody concentration.","timeFrame":"One month post vaccination (Day 30) during pregnancy"},{"measure":"Percentage of Seropositive Subjects Against Anti-PT, Anti-FHA and Anti-PRN in the Cord Blood Samples","description":"For this assay the anti-PT, anti-FHA and anti-PRN seropositivity status was determined from the cord blood samples. The seropositivity cut-offs were the following: 2.693 IU/mL for anti-PT, 2.046 IU/mL for anti-FHA and 2.187 IU/mL for anti-PRN.","timeFrame":"At delivery - Visit 3 (anytime after 27 eligible weeks of gestation)"},{"measure":"Percentage of Subjects With Solicited Local Adverse Events (AEs)","description":"Assessed solicited local symptoms were pain, redness and swelling. \"Any\" = any report of the specified symptom irrespective of intensity grade. Dose 1 = pregnancy dose at Day 0 - Visit 1, Dose 2 = post-delivery dose at birth - Visit 3.","timeFrame":"During the 8-day (Day 0-Day 7) follow-up period after vaccination during pregnancy"},{"measure":"Percentage of Subjects With Solicited General AEs","description":"Assessed solicited general symptoms were fatigue, gastrointestinal symptoms (nausea, vomiting, diarrhoea and/or abdominal pain), headache and fever \\[defined as oral, axillary or tympanic temperature ≥ 37.5 degrees Celsius (°C) or rectal temperature ≥ 38.0 °C\\]. \"Any\" = any report of the specified symptom irrespective of intensity grade. Dose 1 = pregnancy dose at Day 0 - Visit 1, Dose 2 = post-delivery dose at birth - Visit 3.","timeFrame":"During the 8-day (Day 0-Day 7) follow-up period after vaccination during pregnancy"},{"measure":"Percentage of Subjects With Unsolicited AEs","description":"An unsolicited AE was any AE that was not solicited using a subject diary and that was spontaneously communicated by the subject. Also any 'solicited' symptom with onset outside the specified period of follow-up for solicited symptoms was reported as an unsolicited adverse event. Dose 1 = pregnancy dose at Day 0 - Visit 1, Dose 2 = post-delivery dose at birth - Visit 3.","timeFrame":"Within 31 days (Day 0 - Day 30) after each vaccination"},{"measure":"Percentage of Infants With Unsolicited AEs","description":"An unsolicited AE was any AE that was not solicited using a subject diary and that was spontaneously communicated by the subject. Also any 'solicited' symptom with onset outside the specified period of follow-up for solicited symptoms was reported as an unsolicited adverse event.","timeFrame":"From delivery to Month 2 post delivery (Visit 4, end of the study)."},{"measure":"Number of Subjects With Serious AEs (SAEs)","description":"A SAE was any untoward medical occurrence that resulted in death, was life threatening, required hospitalization or prolongation of hospitalization, resulted in disability/incapacity or a congenital anomaly/birth defect in the offspring of a study subject.","timeFrame":"From Day 0 (Visit 1) to Month 2 (Visit 4, end of the study)."},{"measure":"Percentage of Household Contacts of the Infants Born to Pregnant Women Vaccinated in Spain","description":"This analysis assessed the vaccination status of the household contacts (who accepted, received or refused vaccination) and also the reasons for refusal (not coming to site, refused to be vaccinated, unspecified) as part of an assessment of cocooning among the eligible household contacts.","timeFrame":"From Day 0 (Visit 1) to Month 2 (Visit 4, end of the study)."},{"measure":"Percentage of Household Contacts With SAEs","description":"SAEs assessed include medical occurrences that results in death, are life threatening, require hospitalization or prolongation of hospitalization, results in disability/incapacity or are a congenital anomaly/birth defect in the offspring of a study subjects.","timeFrame":"During the 31-day (Days 0-30) follow-up period post-vaccination (Boostrix administered preferably 2 weeks before the birth of the infant, Visit 3)."}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria for study subjects:\n\n* Subjects who, in the opinion of the investigator, can and will comply with the requirements of the protocol.\n* Written informed consent obtained from the subject prior to performing any study specific procedure, as per local regulations.\n* A healthy pregnant woman between, and including, 18 and 45 years of age at the time of screening.\n* Pregnant subjects at 27 0/7-36 6/7 weeks (completed 27 weeks but not 37 weeks) of gestation at the time of vaccination (Visit 1), as established by ultrasound examination.\n* Not at high risk for complications, as determined by the obstetrical algorithm for identification of eligible subjects and the Obstetrical Risk Assessment Form.\n* No significant foetal abnormalities, as observed by the level II ultrasound testing conducted after 18 weeks of gestation.\n* Nuchal translucency scan, serum testing and any other prenatal tests, if conducted, should suggest normal pregnancy.\n* Willing to have the infant born immunised with Infanrix hexa and Prevenar 13, as per national recommendations, in the follow-up clinical studies DTPA (BOOSTRIX)-048 PRI and DTPA (BOOSTRIX)-049 BST: 048.\n* Subjects who do not plan to give their child for adoption or place the child in care.\n\nInclusion criteria for household contacts in Spain:\n\n* Household contacts living in the same house as that of the infant.\n* Household contacts or parent(s)/LAR(s) of the household contacts who, in the opinion of the investigator, can and will comply with the requirements of the protocol (e.g. reporting of SAEs).\n* Written informed consent obtained from the household contacts or the parent(s)/LAR(s) prior to vaccination, as per local regulations.\n* Household contacts who are eligible to receive a booster dose of DTP-containing vaccine according to the Summary of Product Characteristics (SmPC) of Boostrix and according to the local governmental recommendations in Spain.\n* Female household contacts of non-childbearing potential may be enrolled in the study.\n\n  \\- Non-childbearing potential is defined as pre-menarche, current tubal ligation, hysterectomy, ovariectomy or post-menopause.\n* Female household contacts of childbearing potential may be enrolled in the study , if the household contact\n\n  * has practiced adequate contraception for 30 days prior to vaccination,\n  * has a negative pregnancy test on the day of vaccination and\n  * has agreed to continue adequate contraception for 2 months after receiving the vaccine dose.\n\nExclusion Criteria for study subjects:\n\n* Subjects diagnosed with multiple pregnancies (twins, triplets etc.).\n* Previous vaccination containing diphtheria, tetanus or pertussis antigens or diphtheria and tetanus toxoids at any time during the current pregnancy.\n* Women with co-morbid medical or obstetric conditions that in the opinion of the investigator have the potential to complicate the pregnancy course and outcomes.\n* Gestational diabetes as determined by glucose tolerance test conducted after 20 weeks of gestation, as per local recommendations of the country.\n* History of early onset (\\<34 weeks of gestation) of eclampsia/pre-eclampsia in previous pregnancy.\n* History of major congenital anomalies in previous pregnancies.\n* Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine anytime during the current pregnancy or planned use during the study period.\n* Any medical condition that in the judgment of the investigator would make intramuscular injection unsafe.\n* Chronic administration of immunosuppressants or other immune-modifying drugs during the period starting six months prior to the first vaccine. For corticosteroids, this will mean prednisone ≥20 mg/day, or equivalent. Inhaled and topical steroids are allowed.\n* Administration of long-acting immune-modifying drugs at any time during the study period.\n* Planned administration/administration of a vaccine not foreseen by the study protocol in the period within the period starting 30 days before and 30 days after the dose of vaccine with the exception of seasonal influenza vaccine that can be administered anytime during the study period.\n* Concurrently participating in another clinical study, at any time during the study period, in which the subject has been or will be exposed to an investigational or a non-investigational vaccine/product (pharmaceutical product or device).\n* Serious underlying medical condition \\[e.g., immunosuppressive disease or therapy, human immunodeficiency virus infection, collagen vascular disease, epilepsy, diabetes mellitus, chronic hypertension, moderate to severe asthma, lung/heart disease, liver/kidney disease, infections including TORCHES (toxoplasmosis, rubella, cytomegalovirus, herpes simplex, syphilis) infections\\].\n* History of an encephalopathy of unknown aetiology, occurring within 7 days following previous vaccination with pertussis-containing vaccine.\n* History of transient thrombocytopenia or neurological complications (for convulsions or hypotonic-hyporesponsive episodes) following an earlier immunisation against diphtheria and/or tetanus\n* Significant mental illness (e.g. schizophrenia, psychosis and major depression).\n* Family history (first degree relatives only) of congenital anomalies, recurrent pregnancy losses (two or more consecutive losses) and unexplained neonatal death(s) in the subject.\n* Any confirmed or suspected immunosuppressive or immunodeficient condition, based on medical history and physical examination (no laboratory testing required).\n* History of any reaction or hypersensitivity likely to be exacerbated by any component of the vaccine.\n* History of febrile illness within the past 72 hours.\n* History of physician-diagnosed or laboratory-confirmed pertussis within the past five years.\n* Anything that would prevent subject from completing the study or put the subject at risk, as determined by the investigator.\n* Acute disease and/or fever at the time of enrolment.\n\n  * Fever is defined as temperature ≥ 37.5°C /99.5°F for oral, axillary or tympanic route, or ≥ 38.0°C /100.4°F on rectal route.\n  * Subjects with a minor illness (such as mild diarrhoea, mild upper respiratory infection) without fever may be enrolled at the discretion of the investigator.\n* Administration of immunoglobulins and/or any blood products within the 3 months preceding the dose of study vaccine, or planned administration during the study period, with the exception of anti-D (Rh)-immunoglobulin.\n* History of chronic excessive alcohol consumption and/or drug abuse.\n\nExclusion criteria for household contacts in Spain:\n\n* Child in care.\n* Concurrently participating in another clinical study, at any time during the study period, in which the household contact has been or will be exposed to an investigational or a non-investigational product (pharmaceutical product or device).\n* Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine within 30 days preceding the dose of study vaccine, or planned use during the study period.\n* History of any reaction or hypersensitivity likely to be exacerbated by any component of the vaccine.\n* History of an encephalopathy of unknown aetiology, occurring within 7 days following previous vaccination with pertussis-containing vaccine.\n* Acute disease and/or fever at the time of enrolment.\n\n  * Fever is defined as temperature ≥ 37.5°C /99.5°F for oral, axillary or tympanic route, or ≥ 38.0°C /100.4°F on rectal route. The preferred route of recording temperature will be axillary in household contacts.\n  * Household contacts with a minor illness (such as mild diarrhoea, mild upper respiratory infection) without fever may be enrolled at the discretion of the investigator.\n* Anything that would put the household contact at risk, as determined by the investigator.\n* Pregnant or lactating household contacts.\n* Household contacts planning to become pregnant or planning to discontinue contraceptive precautions prior to 2 months post-vaccination.","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"18 Years","maximumAge":"45 Years","stdAges":["ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"GSK Clinical Trials","affiliation":"GlaxoSmithKline","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"GSK Investigational Site","city":"Carlton","state":"Victoria","zip":"3053","country":"Australia","geoPoint":{"lat":-37.8,"lon":144.96667}},{"facility":"GSK Investigational Site","city":"Fitzroy","state":"Victoria","zip":"3065","country":"Australia","geoPoint":{"lat":-37.79839,"lon":144.97833}},{"facility":"GSK Investigational Site","city":"Parkville","state":"Victoria","zip":"3052","country":"Australia","geoPoint":{"lat":-37.78333,"lon":144.95}},{"facility":"GSK Investigational Site","city":"Calgary","state":"Alberta","zip":"T3B 6A8","country":"Canada","geoPoint":{"lat":51.05011,"lon":-114.08529}},{"facility":"GSK Investigational Site","city":"Halifax","state":"Nova Scotia","zip":"B3K 6R8","country":"Canada","geoPoint":{"lat":44.64269,"lon":-63.57688}},{"facility":"GSK Investigational Site","city":"Greater Sudbury","state":"Ontario","zip":"P3A 1W8","country":"Canada","geoPoint":{"lat":46.49,"lon":-80.99001}},{"facility":"GSK Investigational Site","city":"Montreal","state":"Quebec","zip":"H3T 1C5","country":"Canada","geoPoint":{"lat":45.50884,"lon":-73.58781}},{"facility":"GSK Investigational Site","city":"Mount Royal","state":"Quebec","zip":"H3P 3W3","country":"Canada","geoPoint":{"lat":45.51675,"lon":-73.64918}},{"facility":"GSK Investigational Site","city":"Brno","zip":"613 00","country":"Czechia","geoPoint":{"lat":49.19522,"lon":16.60796}},{"facility":"GSK Investigational Site","city":"Hradec Králové","zip":"500 02","country":"Czechia","geoPoint":{"lat":50.20923,"lon":15.83277}},{"facility":"GSK Investigational Site","city":"Ostrava - Vitkovice","zip":"703 84","country":"Czechia"},{"facility":"GSK Investigational Site","city":"Prague","zip":"14059","country":"Czechia","geoPoint":{"lat":50.08804,"lon":14.42076}},{"facility":"GSK Investigational Site","city":"Prague","zip":"14700","country":"Czechia","geoPoint":{"lat":50.08804,"lon":14.42076}},{"facility":"GSK Investigational Site","city":"Kokkola","zip":"67100","country":"Finland","geoPoint":{"lat":63.83847,"lon":23.13066}},{"facility":"GSK Investigational Site","city":"Oulu","zip":"90220","country":"Finland","geoPoint":{"lat":65.01236,"lon":25.46816}},{"facility":"GSK Investigational Site","city":"Seinäjoki","zip":"60100","country":"Finland","geoPoint":{"lat":62.79446,"lon":22.82822}},{"facility":"GSK Investigational Site","city":"Tampere","zip":"33100","country":"Finland","geoPoint":{"lat":61.49911,"lon":23.78712}},{"facility":"GSK Investigational Site","city":"Turku","zip":"20520","country":"Finland","geoPoint":{"lat":60.45148,"lon":22.26869}},{"facility":"GSK Investigational Site","city":"Milan","state":"Lombardy","zip":"20122","country":"Italy","geoPoint":{"lat":45.46427,"lon":9.18951}},{"facility":"GSK Investigational Site","city":"Milan","state":"Lombardy","zip":"20142","country":"Italy","geoPoint":{"lat":45.46427,"lon":9.18951}},{"facility":"GSK Investigational Site","city":"Milan","state":"Lombardy","zip":"20154","country":"Italy","geoPoint":{"lat":45.46427,"lon":9.18951}},{"facility":"GSK Investigational Site","city":"Novara","state":"Piedmont","zip":"28100","country":"Italy","geoPoint":{"lat":45.44694,"lon":8.62118}},{"facility":"GSK Investigational Site","city":"Turin","state":"Piedmont","zip":"10126","country":"Italy","geoPoint":{"lat":45.07049,"lon":7.68682}},{"facility":"GSK Investigational Site","city":"Málaga","state":"Andalusia","zip":"29004","country":"Spain","geoPoint":{"lat":36.72016,"lon":-4.42034}},{"facility":"GSK Investigational Site","city":"Antequera/Málaga","zip":"29200","country":"Spain"},{"facility":"GSK Investigational Site","city":"Aravaca","zip":"28023","country":"Spain","geoPoint":{"lat":40.45772,"lon":-3.78282}},{"facility":"GSK Investigational Site","city":"Boadilla del Monte","zip":"28660","country":"Spain","geoPoint":{"lat":40.405,"lon":-3.87835}},{"facility":"GSK Investigational Site","city":"Burgos","zip":"09006","country":"Spain","geoPoint":{"lat":42.34106,"lon":-3.70184}},{"facility":"GSK Investigational Site","city":"Madrid","zip":"28040","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Madrid","zip":"28046","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Majadahonda (Madrid)","zip":"28222","country":"Spain","geoPoint":{"lat":40.47353,"lon":-3.87182}},{"facility":"GSK Investigational Site","city":"Móstoles","zip":"28938","country":"Spain","geoPoint":{"lat":40.32234,"lon":-3.86496}},{"facility":"GSK Investigational Site","city":"Santiago de Compostela","zip":"15706","country":"Spain","geoPoint":{"lat":42.88052,"lon":-8.54569}},{"facility":"GSK Investigational Site","city":"Seville","zip":"41013","country":"Spain","geoPoint":{"lat":37.38283,"lon":-5.97317}},{"facility":"GSK Investigational Site","city":"Seville","zip":"41940","country":"Spain","geoPoint":{"lat":37.38283,"lon":-5.97317}}]},"referencesModule":{"references":[{"pmid":"31776029","type":"BACKGROUND","citation":"Perrett KP, Halperin SA, Nolan T, Martinez Pancorbo C, Tapiero B, Martinon-Torres F, Stranak Z, Virta M, Vanderkooi OG, Kosina P, Encinas Pardilla MB, Cristobal Garcia I, Zuccotti GV, Kostanyan L, Meyer N, Ceregido MA, Cheuvart B, Kuriyakose SO, Marcos Fernandez M, Rodriguez Zambrano MA, Martin Garcia A, Asenjo de la Fuente JE, Camacho Marin MD, de la Calle Fernandez-Miranda M, Romero Espinar Y, Marchisio PG, Manzoni P, Mesaros N. Immunogenicity, transplacental transfer of pertussis antibodies and safety following pertussis immunization during pregnancy: Evidence from a randomized, placebo-controlled trial. Vaccine. 2020 Feb 18;38(8):2095-2104. doi: 10.1016/j.vaccine.2019.10.105. Epub 2019 Nov 24."}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"IPD for this study will be made available via the Clinical Study Data Request site.","infoTypes":["STUDY_PROTOCOL","SAP","ICF","CSR"],"timeFrame":"IPD will be made available within 6 months of publishing the results of the primary endpoints of the study.","accessCriteria":"Access is provided after a research proposal is submitted and has received approval from the Independent Review Panel and after a Data Sharing Agreement is in place. Access is provided for an initial period of 12 months but an extension can be granted, when justified, for up to another 12 months.","url":"http://clinicalstudydatarequest.com"}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"Safety was assessed for infants born to vaccinated subjects as well as safety of dTap vaccination in the vaccinated pregnant subjects. There was also an assessment of the acceptance rate of a single dose of Boostrix among 723 eligible household contacts of the infants born to pregnant women enrolled in Spain, as part of an assessment of cocooning.","recruitmentDetails":"A total of 725 pregnant subjects were screened of which 690 were randomized to 2 groups. Of these, 2 subjects were withdrawn before vaccination. Therefore 688 subjects were enrolled: 1 subject was excluded from the statistical analysis, leaving 687 subjects that comprised the Total Vaccinated cohort.","groups":[{"id":"FG000","title":"dTpa Group - Mother","description":"This group consisted of pregnant women who received a single dose of Boostrix at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of the placebo post-delivery (within 72 hours)."},{"id":"FG001","title":"Control Group - Mother","description":"This group consisted of pregnant women who received a single dose of placebo at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of Boostrix post-delivery (within 72 hours)."}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"341"},{"groupId":"FG001","numSubjects":"346"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"325"},{"groupId":"FG001","numSubjects":"335"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"16"},{"groupId":"FG001","numSubjects":"11"}]}],"dropWithdraws":[{"type":"Serious Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"}]},{"type":"Protocol Violation","reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"2"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"5"},{"groupId":"FG001","numSubjects":"3"}]},{"type":"Lost to follow-up (partial vaccination)","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"}]},{"type":"Lost to follow-up (complete vaccination)","reasons":[{"groupId":"FG000","numSubjects":"6"},{"groupId":"FG001","numSubjects":"5"}]},{"type":"Other","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"dTpa Group - Mother","description":"This group consisted of pregnant women who received a single dose of Boostrix at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of the placebo post-delivery (within 72 hours)."},{"id":"BG001","title":"Control Group - Mother","description":"This group consisted of pregnant women who received a single dose of placebo at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of Boostrix post-delivery (within 72 hours)."},{"id":"BG002","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"341"},{"groupId":"BG001","value":"346"},{"groupId":"BG002","value":"687"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"Years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"32.7","spread":"4.4"},{"groupId":"BG001","value":"32.5","spread":"4.3"},{"groupId":"BG002","value":"32.6","spread":"4.35"}]}]}]},{"title":"Sex/Gender, Customized","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"Female","categories":[{"measurements":[{"groupId":"BG000","value":"341"},{"groupId":"BG001","value":"346"},{"groupId":"BG002","value":"687"}]}]},{"title":"Male","categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]}]}]},{"title":"Race/Ethnicity, Customized","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"African Heritage / African American","categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"12"}]}]},{"title":"American Indian or Alaskan Native","categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"2"}]}]},{"title":"Asian - Central/South Asian Heritage","categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"3"}]}]},{"title":"Asian - East Asian Heritage","categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"5"}]}]},{"title":"Asian - Japanese Heritage","categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}]}]},{"title":"Asian - South East Asian Heritage","categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}]}]},{"title":"White - Arabic / North African Heritage","categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"10"}]}]},{"title":"White - Caucasian / European Heritage","categories":[{"measurements":[{"groupId":"BG000","value":"314"},{"groupId":"BG001","value":"319"},{"groupId":"BG002","value":"633"}]}]},{"title":"Unspecified","categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"19"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Antibody Concentrations Against Pertussis Toxoid Antigen (Anti-PT), Filamentous Haemagglutinin Antigen (Anti-FHA) and Pertactin Antigen (Anti-PRN) in Cord Blood Samples","description":"Antibody concentrations were assessed by Enzyme-linked immunosorbent assay (ELISA), tabulated as Geometric Mean Concentrations (GMCs) and expressed in International units per mililiter (IU/mL) for the following assay cut-offs: 2.693 IU/mL for anti-PT, 2.046 IU/mL for anti-FHA and 2.187 IU/mL for anti-PRN.","populationDescription":"The analysis was done on the According to protocol cohort for immunogenicity , which included all evaluable subjects who complied with the vaccine administration, who had cord blood collected at least 21 days post-vaccination and for whom data concerning antibodies against at least 1 study vaccine antigen component at Visit 3 were available.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"IU/mL","timeFrame":"At delivery - Visit 3 (anytime after 28 weeks of gestation)","groups":[{"id":"OG000","title":"dTpa Group - Mother","description":"This group consisted of pregnant women who received a single dose of Boostrix at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of the placebo post-delivery (within 72 hours)."},{"id":"OG001","title":"Control Group - Mother","description":"This group consisted of pregnant women who received a single dose of placebo at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of Boostrix post-delivery (within 72 hours)."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"291"},{"groupId":"OG001","value":"292"}]}],"classes":[{"title":"Anti-PT","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"290"},{"groupId":"OG001","value":"292"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"46.9","lowerLimit":"41.2","upperLimit":"53.3"},{"groupId":"OG001","value":"5.5","lowerLimit":"4.8","upperLimit":"6.3"}]}]},{"title":"Anti-FHA","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"291"},{"groupId":"OG001","value":"292"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"366.1","lowerLimit":"329","upperLimit":"407.3"},{"groupId":"OG001","value":"22.7","lowerLimit":"19.7","upperLimit":"26.2"}]}]},{"title":"Anti-PRN","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"290"},{"groupId":"OG001","value":"291"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"301.8","lowerLimit":"250.9","upperLimit":"362.9"},{"groupId":"OG001","value":"14.6","lowerLimit":"12.1","upperLimit":"17.7"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"groupDescription":"GMC ratio between groups (dTpa Group-Mother/Control Group-Mother) to demonstrate that maternally transferred antibodies against pertussis in the dTpa Group-Mother was superior to that in the Control Group-mother, in the cord blood sample at the time of delivery.","nonInferiorityType":"SUPERIORITY","nonInferiorityComment":"Criterion: The lower limit (LL) of the 95% confidence interval (CI) of the GMC ratio \\[dTpa Group-Mother/Control Group-Mother\\] for anti-PT antibodies was greater than or equal to (≥) 1.5.","statisticalMethod":"2-sample t-test","statisticalComment":"The CI of the group GMC ratio were computed using two-sample t-test assuming heterogeneity of variance.","paramType":"GMC ratio","paramValue":"8.47","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"7.02","ciUpperLimit":"10.2"},{"groupIds":["OG000","OG001"],"groupDescription":"GMC ratio between groups (dTpa Group-Mother/Control Group-Mother) to demonstrate that maternally transferred antibodies against pertussis in the dTpa Group-Mother was superior to that in the Control Group-mother, in the cord blood sample at the time of delivery.","nonInferiorityType":"SUPERIORITY","nonInferiorityComment":"Criterion: The lower limit (LL) of the 95% confidence interval (CI) of the GMC ratio \\[dTpa Group-Mother/Control Group-Mother\\] for anti-FHA antibodies was greater than or equal to (≥) 1.5.","statisticalMethod":"2-sample t-test","statisticalComment":"The CI of the group GMC ratio were computed using two-sample t-test assuming heterogeneity of variance.","paramType":"GMC ratio","paramValue":"16.11","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"13.48","ciUpperLimit":"19.24"},{"groupIds":["OG000","OG001"],"groupDescription":"GMC ratio between groups (dTpa Group-Mother/Control Group-Mother) to demonstrate that maternally transferred antibodies against pertussis in the dTpa Group-Mother was superior to that in the Control Group-mother, in the cord blood sample at the time of delivery.","nonInferiorityType":"SUPERIORITY","nonInferiorityComment":"Criterion: The lower limit (LL) of the 95% confidence interval (CI) of the GMC ratio \\[dTpa Group-Mother/Control Group-Mother\\] for anti-PRN antibodies was greater than or equal to (≥) 1.5.","statisticalMethod":"2-sample t-test","statisticalComment":"The CI of the group GMC ratio were computed using two-sample t-test assuming heterogeneity of variance.","paramType":"GMC ratio","paramValue":"20.65","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"15.86","ciUpperLimit":"26.88"}]},{"type":"SECONDARY","title":"Percentage of Subjects by Pregnancy Outcomes","description":"Pregnancy outcomes included live birth with no congenital anomalies, live birth with congenital anomalies, still birth with no congenital anomalies, still birth with congenital anomalies, elective termination with no congenital anomalies and elective termination with congenital anomalies. No subjects with still birth or elective termination of infant were reported.","populationDescription":"This analysis was performed on the Total Vaccinated cohort (TVC) which included all subjects with the study vaccine administration documented.","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Percentage of subjects","timeFrame":"From Day 0 (Visit 1) to Month 2 (Visit 4, end of the study).","groups":[{"id":"OG000","title":"dTpa Group - Mother","description":"This group consisted of pregnant women who received a single dose of Boostrix at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of the placebo post-delivery (within 72 hours)."},{"id":"OG001","title":"Control Group - Mother","description":"This group consisted of pregnant women who received a single dose of placebo at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of Boostrix post-delivery (within 72 hours)."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"341"},{"groupId":"OG001","value":"346"}]}],"classes":[{"title":"Live infant No apparent congenital anomaly","categories":[{"measurements":[{"groupId":"OG000","value":"97.4","lowerLimit":"95","upperLimit":"98.8"},{"groupId":"OG001","value":"97.4","lowerLimit":"95.1","upperLimit":"98.8"}]}]},{"title":"Live infant congenital anomaly","categories":[{"measurements":[{"groupId":"OG000","value":"2.6","lowerLimit":"1.2","upperLimit":"5"},{"groupId":"OG001","value":"2.3","lowerLimit":"1","upperLimit":"4.5"}]}]},{"title":"Lost to follow-up","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0","upperLimit":"1.1"},{"groupId":"OG001","value":"0.3","lowerLimit":"0","upperLimit":"1.6"}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects With Listed Pregnancy/Neonate Related Adverse Events of Interest","description":"Listed pregnancy-related adverse events of interest/ neonate-related events of interest included gestational diabetes, pregnancy-related hypertension, premature rupture of mem-branes, preterm premature rupture of membranes, premature labour, premature uterine contractions, intrauterine growth restriction/poor foetal growth, pre-eclampsia, eclampsia, vaginal or intrauterine haemorrhage, maternal death, preterm birth, neonatal death, small for gestational age, neonatal hypoxic ischaemic encephalopathy and failure to thrive/growth deficiency were reported.","populationDescription":"This analysis was performed on the TVC which included all subjects with the study vaccine administration documented.","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Percentage of subjects","timeFrame":"From Day 0 (Visit 1) to Month 2 post-delivery (Visit 4, end of the study).","groups":[{"id":"OG000","title":"dTpa Group - Mother","description":"This group consisted of pregnant women who received a single dose of Boostrix at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of the placebo post-delivery (within 72 hours)."},{"id":"OG001","title":"Control Group - Mother","description":"This group consisted of pregnant women who received a single dose of placebo at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of Boostrix post-delivery (within 72 hours)."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"341"},{"groupId":"OG001","value":"346"}]}],"classes":[{"title":"Intrauterine growth restriction/poor foetal growth","categories":[{"measurements":[{"groupId":"OG000","value":"1.5","lowerLimit":"0.5","upperLimit":"3.4"},{"groupId":"OG001","value":"0.6","lowerLimit":"0.1","upperLimit":"2.1"}]}]},{"title":"Pre-eclampsia","categories":[{"measurements":[{"groupId":"OG000","value":"0.3","lowerLimit":"0","upperLimit":"1.6"},{"groupId":"OG001","value":"1.4","lowerLimit":"0.5","upperLimit":"3.3"}]}]},{"title":"Pregnancy-related hypertension","categories":[{"measurements":[{"groupId":"OG000","value":"1.2","lowerLimit":"0.3","upperLimit":"3"},{"groupId":"OG001","value":"1.4","lowerLimit":"0.5","upperLimit":"3.3"}]}]},{"title":"Premature labour","categories":[{"measurements":[{"groupId":"OG000","value":"3.8","lowerLimit":"2","upperLimit":"6.4"},{"groupId":"OG001","value":"3.2","lowerLimit":"1.6","upperLimit":"5.6"}]}]},{"title":"Premature rupture of membranes","categories":[{"measurements":[{"groupId":"OG000","value":"3.8","lowerLimit":"2","upperLimit":"6.4"},{"groupId":"OG001","value":"4.3","lowerLimit":"2.4","upperLimit":"7"}]}]},{"title":"Premature uterine contractions","categories":[{"measurements":[{"groupId":"OG000","value":"0.6","lowerLimit":"0.1","upperLimit":"2.1"},{"groupId":"OG001","value":"0.9","lowerLimit":"0.2","upperLimit":"2.5"}]}]},{"title":"Preterm birth","categories":[{"measurements":[{"groupId":"OG000","value":"3.2","lowerLimit":"1.6","upperLimit":"5.7"},{"groupId":"OG001","value":"2.6","lowerLimit":"1.2","upperLimit":"4.9"}]}]},{"title":"Preterm premature rupture of membranes","categories":[{"measurements":[{"groupId":"OG000","value":"1.2","lowerLimit":"0.3","upperLimit":"3"},{"groupId":"OG001","value":"2","lowerLimit":"0.8","upperLimit":"4.1"}]}]},{"title":"Small for gestational age","categories":[{"measurements":[{"groupId":"OG000","value":"0.6","lowerLimit":"0.1","upperLimit":"2.1"},{"groupId":"OG001","value":"0.6","lowerLimit":"0.1","upperLimit":"2.1"}]}]},{"title":"Vaginal or intrauterine haemorrhage","categories":[{"measurements":[{"groupId":"OG000","value":"2.6","lowerLimit":"1.2","upperLimit":"5"},{"groupId":"OG001","value":"2.9","lowerLimit":"1.4","upperLimit":"5.3"}]}]}]},{"type":"SECONDARY","title":"Percentage of Seroprotected Subjects Against Diphteria Antigen (Anti-D), Tetanus Antigen (Anti-T) and of Seropositive Subjects Against Anti-PT, Anti-FHA and Anti-PRN","description":"A seroprotected subject against diphteria and tetanus was a subject with antibody concentration ≥ 0.1 IU/mL. A seropositive subject was a subjects with antibody concentration ≥ 2.693 IU/mL for anti-PT, ≥ 2.046 IU/mL for anti-FHA and ≥ 2.187 IU/mL for anti-PRN.","populationDescription":"The analysis was done on the According to protocol cohort for immunogenicity , which included all evaluable subjects who complied with the vaccine administration and for whom data concerning antibodies against at least 1 study vaccine antigen component at Visit 2 were available.","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Percentage of subjects","timeFrame":"One month post vaccination (Day 30) during pregnancy","groups":[{"id":"OG000","title":"dTpa Group - Mother","description":"This group consisted of pregnant women who received a single dose of Boostrix at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of the placebo post-delivery (within 72 hours)."},{"id":"OG001","title":"Control Group - Mother","description":"This group consisted of pregnant women who received a single dose of placebo at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of Boostrix post-delivery (within 72 hours)."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"290"},{"groupId":"OG001","value":"292"}]}],"classes":[{"title":"Anti-D","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"290"},{"groupId":"OG001","value":"289"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"97.6","lowerLimit":"95.1","upperLimit":"99"},{"groupId":"OG001","value":"70.6","lowerLimit":"65","upperLimit":"75.8"}]}]},{"title":"Anti-T","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"290"},{"groupId":"OG001","value":"292"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"100","lowerLimit":"98.7","upperLimit":"100"},{"groupId":"OG001","value":"96.6","lowerLimit":"93.8","upperLimit":"98.3"}]}]},{"title":"Anti-PT","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"289"},{"groupId":"OG001","value":"292"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"98.6","lowerLimit":"96.5","upperLimit":"99.6"},{"groupId":"OG001","value":"61.3","lowerLimit":"55.5","upperLimit":"66.9"}]}]},{"title":"Anti-FHA","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"290"},{"groupId":"OG001","value":"291"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"100","lowerLimit":"98.7","upperLimit":"100"},{"groupId":"OG001","value":"94.5","lowerLimit":"91.2","upperLimit":"96.8"}]}]},{"title":"Anti-PRN","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"290"},{"groupId":"OG001","value":"291"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"100","lowerLimit":"98.7","upperLimit":"100"},{"groupId":"OG001","value":"84.5","lowerLimit":"79.9","upperLimit":"88.5"}]}]}]},{"type":"SECONDARY","title":"Anti-D, Anti-T, Anti-PT, Anti-FHA and Anti-PRN Antibody Concentrations","description":"Antibody concentrations were determined by ELISA, tabulated as GMCs and expressed in IU/mL.","populationDescription":"The analysis was done on the According to protocol cohort for immunogenicity , which included all evaluable subjects who complied with the vaccine administration and for whom data concerning antibodies against at least 1 study vaccine antigen component at Visit 2 were available.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"IU/mL","timeFrame":"One month post vaccination (Day 30) during pregnancy","groups":[{"id":"OG000","title":"dTpa Group - Mother","description":"This group consisted of pregnant women who received a single dose of Boostrix at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of the placebo post-delivery (within 72 hours)."},{"id":"OG001","title":"Control Group - Mother","description":"This group consisted of pregnant women who received a single dose of placebo at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of Boostrix post-delivery (within 72 hours)."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"290"},{"groupId":"OG001","value":"292"}]}],"classes":[{"title":"Anti-D","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"290"},{"groupId":"OG001","value":"289"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2.19","lowerLimit":"1.87","upperLimit":"2.57"},{"groupId":"OG001","value":"0.23","lowerLimit":"0.19","upperLimit":"0.27"}]}]},{"title":"Anti-T","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"290"},{"groupId":"OG001","value":"292"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8.43","lowerLimit":"7.72","upperLimit":"9.2"},{"groupId":"OG001","value":"0.98","lowerLimit":"0.86","upperLimit":"1.11"}]}]},{"title":"Anti-PT","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"289"},{"groupId":"OG001","value":"292"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"45.6","lowerLimit":"40.4","upperLimit":"51.5"},{"groupId":"OG001","value":"4.1","lowerLimit":"3.6","upperLimit":"4.6"}]}]},{"title":"Anti-FHA","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"290"},{"groupId":"OG001","value":"291"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"317.5","lowerLimit":"285","upperLimit":"353.8"},{"groupId":"OG001","value":"15","lowerLimit":"13.1","upperLimit":"17.2"}]}]},{"title":"Anti-PRN","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"290"},{"groupId":"OG001","value":"291"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"283.6","lowerLimit":"237.1","upperLimit":"339.1"},{"groupId":"OG001","value":"10.5","lowerLimit":"8.7","upperLimit":"12.5"}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects With Vaccine Response to Anti-D and Anti-T","description":"Vaccine response for anti-D and anti-T was defined as:\n\nfor initially seronegative subjects (S-) with pre-vaccination concentration below cut-off: \\< 0.1 IU/mL) was an antibody concentration at least four times the assay cut-off (post-vaccination concentration ≥ 0.4 IU/mL); for initially seropositive subjects (S+) with pre-vaccination concentration ≥ 0.1 IU/mL): an increase in antibody concentrations of at least four times the pre-vaccination concentration.","populationDescription":"The analysis was done on the According to protocol cohort for immunogenicity , which included all evaluable subjects who complied with the vaccine administration and for whom data concerning antibodies against at least 1 study vaccine antigen component at Visit 2 were available.","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Percentage of subjects","timeFrame":"One month post vaccination (Day 30) during pregnancy","groups":[{"id":"OG000","title":"dTpa Group - Mother","description":"This group consisted of pregnant women who received a single dose of Boostrix at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of the placebo post-delivery (within 72 hours)."},{"id":"OG001","title":"Control Group - Mother","description":"This group consisted of pregnant women who received a single dose of placebo at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of Boostrix post-delivery (within 72 hours)."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"288"},{"groupId":"OG001","value":"291"}]}],"classes":[{"title":"Anti-D, S-","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"103"},{"groupId":"OG001","value":"83"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"64.1","lowerLimit":"54","upperLimit":"73.3"},{"groupId":"OG001","value":"0","lowerLimit":"0","upperLimit":"4.3"}]}]},{"title":"Anti-D, S+","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"184"},{"groupId":"OG001","value":"205"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"75","lowerLimit":"68.1","upperLimit":"81.1"},{"groupId":"OG001","value":"0","lowerLimit":"0","upperLimit":"1.8"}]}]},{"title":"Anti-D, Total","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"287"},{"groupId":"OG001","value":"288"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"71.1","lowerLimit":"65.5","upperLimit":"76.3"},{"groupId":"OG001","value":"0","lowerLimit":"0","upperLimit":"1.3"}]}]},{"title":"Anti-T, S-","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"10"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"100","lowerLimit":"73.5","upperLimit":"100"},{"groupId":"OG001","value":"0","lowerLimit":"0","upperLimit":"30.8"}]}]},{"title":"Anti-T, S+","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"276"},{"groupId":"OG001","value":"281"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"67.8","lowerLimit":"61.9","upperLimit":"73.2"},{"groupId":"OG001","value":"0","lowerLimit":"0","upperLimit":"1.3"}]}]},{"title":"Anti-T, Total","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"288"},{"groupId":"OG001","value":"291"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"69.1","lowerLimit":"63.4","upperLimit":"74.4"},{"groupId":"OG001","value":"0","lowerLimit":"0","upperLimit":"1.3"}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects With Vaccine Response to Anti-PT, Anti-FHA and Anti-PRN","description":"Vaccine response to PT, FHA and PRN antigens is defined as: for subjects with pre-vaccination antibody concentration below the assay cut-off (S-), post-vaccination anti-body concentration ≥ 4 times the assay cut-off; for subjects with pre-vaccination antibody concentration between the assay cut-off and below 4 times the assay cut-off (S+), post-vaccination antibody concentration ≥ 4 times the pre-vaccination antibody concentration, and for subjects with pre-vaccination antibody concentration ≥4 times the assay cut-off (S+), post-vaccination antibody concentration ≥2 times the pre-vaccination antibody concentration.","populationDescription":"The analysis was done on the According to protocol cohort for immunogenicity , which included all evaluable subjects who complied with the vaccine administration and for whom data concerning antibodies against at least 1 study vaccine antigen component at Visit 2 were available.","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Percentage of subjects","timeFrame":"One month post vaccination (Day 30) during pregnancy","groups":[{"id":"OG000","title":"dTpa Group - Mother","description":"This group consisted of pregnant women who received a single dose of Boostrix at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of the placebo post-delivery (within 72 hours)."},{"id":"OG001","title":"Control Group - Mother","description":"This group consisted of pregnant women who received a single dose of placebo at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of Boostrix post-delivery (within 72 hours)."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"288"},{"groupId":"OG001","value":"291"}]}],"classes":[{"title":"Anti-PT, S-","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"121"},{"groupId":"OG001","value":"107"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"82.6","lowerLimit":"74.7","upperLimit":"88.9"},{"groupId":"OG001","value":"0.9","lowerLimit":"0","upperLimit":"5.1"}]}]},{"title":"Anti-PT, S+ (<4 cut-off)","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"108"},{"groupId":"OG001","value":"117"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"90.7","lowerLimit":"83.6","upperLimit":"95.5"},{"groupId":"OG001","value":"0","lowerLimit":"0","upperLimit":"3.1"}]}]},{"title":"Anti-PT, S+ (≥4 cut-off)","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"67"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"93.1","lowerLimit":"83.3","upperLimit":"98.1"},{"groupId":"OG001","value":"3","lowerLimit":"0.4","upperLimit":"10.4"}]}]},{"title":"Anti-PT, Total","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"287"},{"groupId":"OG001","value":"291"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"87.8","lowerLimit":"83.4","upperLimit":"91.4"},{"groupId":"OG001","value":"1","lowerLimit":"0.2","upperLimit":"3"}]}]},{"title":"Anti-FHA, S-","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"16"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"100","lowerLimit":"79.4","upperLimit":"100"},{"groupId":"OG001","value":"0","lowerLimit":"0","upperLimit":"20.6"}]}]},{"title":"Anti-FHA, S+ (<4 cut-off)","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"84"},{"groupId":"OG001","value":"65"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"100","lowerLimit":"95.7","upperLimit":"100"},{"groupId":"OG001","value":"0","lowerLimit":"0","upperLimit":"5.5"}]}]},{"title":"Anti-FHA, S+ (≥4 cut-off)","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"188"},{"groupId":"OG001","value":"209"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"89.9","lowerLimit":"84.7","upperLimit":"93.8"},{"groupId":"OG001","value":"1.9","lowerLimit":"0.5","upperLimit":"4.8"}]}]},{"title":"Anti-FHA, Total","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"288"},{"groupId":"OG001","value":"290"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"93.4","lowerLimit":"89.9","upperLimit":"96"},{"groupId":"OG001","value":"1.4","lowerLimit":"0.4","upperLimit":"3.5"}]}]},{"title":"Anti-PRN, S-","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"45"},{"groupId":"OG001","value":"43"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"86.7","lowerLimit":"73.2","upperLimit":"94.9"},{"groupId":"OG001","value":"0","lowerLimit":"0","upperLimit":"8.2"}]}]},{"title":"Anti-PRN, S+ (<4 cut-off)","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"98"},{"groupId":"OG001","value":"86"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"95.9","lowerLimit":"89.9","upperLimit":"98.9"},{"groupId":"OG001","value":"0","lowerLimit":"0","upperLimit":"4.2"}]}]},{"title":"Anti-PRN, S+ (≥4 cut-off)","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"145"},{"groupId":"OG001","value":"161"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"86.2","lowerLimit":"79.5","upperLimit":"91.4"},{"groupId":"OG001","value":"1.2","lowerLimit":"0.2","upperLimit":"4.4"}]}]},{"title":"Anti-PRN Total","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"288"},{"groupId":"OG001","value":"290"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"89.6","lowerLimit":"85.5","upperLimit":"92.9"},{"groupId":"OG001","value":"0.7","lowerLimit":"0.1","upperLimit":"2.5"}]}]}]},{"type":"SECONDARY","title":"Percentage of Seropositive Subjects Against Anti-PT, Anti-FHA and Anti-PRN in the Cord Blood Samples","description":"For this assay the anti-PT, anti-FHA and anti-PRN seropositivity status was determined from the cord blood samples. The seropositivity cut-offs were the following: 2.693 IU/mL for anti-PT, 2.046 IU/mL for anti-FHA and 2.187 IU/mL for anti-PRN.","populationDescription":"The analysis was done on the According to protocol cohort for immunogenicity , which included all evaluable subjects who complied with the vaccine administration, who had cord blood collected at least 21 days post-vaccination and for whom data concerning antibodies against at least 1 study vaccine antigen component at Visit 3 were available.","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Percentage of subjects","timeFrame":"At delivery - Visit 3 (anytime after 27 eligible weeks of gestation)","groups":[{"id":"OG000","title":"dTpa Group - Mother","description":"This group consisted of pregnant women who received a single dose of Boostrix at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of the placebo post-delivery (within 72 hours)."},{"id":"OG001","title":"Control Group - Mother","description":"This group consisted of pregnant women who received a single dose of placebo at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of Boostrix post-delivery (within 72 hours)."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"291"},{"groupId":"OG001","value":"292"}]}],"classes":[{"title":"Anti-PT","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"290"},{"groupId":"OG001","value":"292"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"98.6","lowerLimit":"96.5","upperLimit":"99.6"},{"groupId":"OG001","value":"68.8","lowerLimit":"63.2","upperLimit":"74.1"}]}]},{"title":"Anti-FHA","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"291"},{"groupId":"OG001","value":"292"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"100","lowerLimit":"98.7","upperLimit":"100"},{"groupId":"OG001","value":"96.6","lowerLimit":"93.8","upperLimit":"98.3"}]}]},{"title":"Anti-PRN","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"290"},{"groupId":"OG001","value":"291"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"99.7","lowerLimit":"98.1","upperLimit":"100"},{"groupId":"OG001","value":"88","lowerLimit":"83.7","upperLimit":"91.5"}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects With Solicited Local Adverse Events (AEs)","description":"Assessed solicited local symptoms were pain, redness and swelling. \"Any\" = any report of the specified symptom irrespective of intensity grade. Dose 1 = pregnancy dose at Day 0 - Visit 1, Dose 2 = post-delivery dose at birth - Visit 3.","populationDescription":"The analysis was done on the TVC, which included all subjects with the study vaccine administration documented and who had returned their diary cards.","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Percentage of subjects","timeFrame":"During the 8-day (Day 0-Day 7) follow-up period after vaccination during pregnancy","groups":[{"id":"OG000","title":"dTpa Group - Mother","description":"This group consisted of pregnant women who received a single dose of Boostrix at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of the placebo post-delivery (within 72 hours)."},{"id":"OG001","title":"Control Group - Mother","description":"This group consisted of pregnant women who received a single dose of placebo at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of Boostrix post-delivery (within 72 hours)."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"335"},{"groupId":"OG001","value":"343"}]}],"classes":[{"title":"Any Pain, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"335"},{"groupId":"OG001","value":"343"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"86.3","lowerLimit":"82.1","upperLimit":"89.8"},{"groupId":"OG001","value":"14.6","lowerLimit":"11","upperLimit":"18.8"}]}]},{"title":"Any Redness (mm), Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"335"},{"groupId":"OG001","value":"343"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"28.7","lowerLimit":"23.9","upperLimit":"33.8"},{"groupId":"OG001","value":"12.8","lowerLimit":"9.5","upperLimit":"16.8"}]}]},{"title":"Any Swelling (mm), Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"335"},{"groupId":"OG001","value":"343"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"25.1","lowerLimit":"20.5","upperLimit":"30.1"},{"groupId":"OG001","value":"3.5","lowerLimit":"1.8","upperLimit":"6"}]}]},{"title":"Any Pain, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"324"},{"groupId":"OG001","value":"330"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12.7","lowerLimit":"9.2","upperLimit":"16.8"},{"groupId":"OG001","value":"62.7","lowerLimit":"57.3","upperLimit":"68"}]}]},{"title":"Any Redness (mm), Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"324"},{"groupId":"OG001","value":"330"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"10.5","lowerLimit":"7.4","upperLimit":"14.4"},{"groupId":"OG001","value":"29.7","lowerLimit":"24.8","upperLimit":"34.9"}]}]},{"title":"Any Swelling (mm), Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"324"},{"groupId":"OG001","value":"330"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5.2","lowerLimit":"3.1","upperLimit":"8.3"},{"groupId":"OG001","value":"26.4","lowerLimit":"21.7","upperLimit":"31.5"}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects With Solicited General AEs","description":"Assessed solicited general symptoms were fatigue, gastrointestinal symptoms (nausea, vomiting, diarrhoea and/or abdominal pain), headache and fever \\[defined as oral, axillary or tympanic temperature ≥ 37.5 degrees Celsius (°C) or rectal temperature ≥ 38.0 °C\\]. \"Any\" = any report of the specified symptom irrespective of intensity grade. Dose 1 = pregnancy dose at Day 0 - Visit 1, Dose 2 = post-delivery dose at birth - Visit 3.","populationDescription":"The analysis was done on the TVC, which included all subjects with the study vaccine administration documented and who had returned their diary cards.","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Percentage of subjects","timeFrame":"During the 8-day (Day 0-Day 7) follow-up period after vaccination during pregnancy","groups":[{"id":"OG000","title":"dTpa Group - Mother","description":"This group consisted of pregnant women who received a single dose of Boostrix at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of the placebo post-delivery (within 72 hours)."},{"id":"OG001","title":"Control Group - Mother","description":"This group consisted of pregnant women who received a single dose of placebo at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of Boostrix post-delivery (within 72 hours)."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"335"},{"groupId":"OG001","value":"342"}]}],"classes":[{"title":"Any Fatigue, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"335"},{"groupId":"OG001","value":"342"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"43.6","lowerLimit":"38.2","upperLimit":"49.1"},{"groupId":"OG001","value":"36.3","lowerLimit":"31.2","upperLimit":"41.6"}]}]},{"title":"Any Gastrointestinal symptom, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"335"},{"groupId":"OG001","value":"342"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"17.9","lowerLimit":"14","upperLimit":"22.4"},{"groupId":"OG001","value":"15.2","lowerLimit":"11.6","upperLimit":"19.5"}]}]},{"title":"Any Headache, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"335"},{"groupId":"OG001","value":"342"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"24.8","lowerLimit":"20.2","upperLimit":"29.8"},{"groupId":"OG001","value":"22.8","lowerLimit":"18.5","upperLimit":"27.6"}]}]},{"title":"Any Temperature/(Axillary) (°C), Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"335"},{"groupId":"OG001","value":"342"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1.2","lowerLimit":"0.3","upperLimit":"3"},{"groupId":"OG001","value":"0.9","lowerLimit":"0.2","upperLimit":"2.5"}]}]},{"title":"Any Fatigue, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"324"},{"groupId":"OG001","value":"331"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"40.1","lowerLimit":"34.7","upperLimit":"45.7"},{"groupId":"OG001","value":"46.2","lowerLimit":"40.8","upperLimit":"51.8"}]}]},{"title":"Any Gastrointestinal symptom, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"324"},{"groupId":"OG001","value":"331"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"9.9","lowerLimit":"6.9","upperLimit":"13.7"},{"groupId":"OG001","value":"12.7","lowerLimit":"9.3","upperLimit":"16.8"}]}]},{"title":"Any Headache, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"324"},{"groupId":"OG001","value":"331"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"23.1","lowerLimit":"18.7","upperLimit":"28.1"},{"groupId":"OG001","value":"23.6","lowerLimit":"19.1","upperLimit":"28.5"}]}]},{"title":"Any Temperature/(Axillary) (°C), Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"324"},{"groupId":"OG001","value":"331"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4.6","lowerLimit":"2.6","upperLimit":"7.5"},{"groupId":"OG001","value":"9.1","lowerLimit":"6.2","upperLimit":"12.7"}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects With Unsolicited AEs","description":"An unsolicited AE was any AE that was not solicited using a subject diary and that was spontaneously communicated by the subject. Also any 'solicited' symptom with onset outside the specified period of follow-up for solicited symptoms was reported as an unsolicited adverse event. Dose 1 = pregnancy dose at Day 0 - Visit 1, Dose 2 = post-delivery dose at birth - Visit 3.","populationDescription":"The analysis was done on the TVC, which included all subjects with the study vaccine administration documented and who had returned their diary cards.","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Percentage of subjects","timeFrame":"Within 31 days (Day 0 - Day 30) after each vaccination","groups":[{"id":"OG000","title":"dTpa Group - Mother","description":"This group consisted of pregnant women who received a single dose of Boostrix at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of the placebo post-delivery (within 72 hours)."},{"id":"OG001","title":"Control Group - Mother","description":"This group consisted of pregnant women who received a single dose of placebo at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of Boostrix post-delivery (within 72 hours)."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"341"},{"groupId":"OG001","value":"346"}]}],"classes":[{"title":"Any unsolicited AE, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"341"},{"groupId":"OG001","value":"346"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"38.7","lowerLimit":"33.5","upperLimit":"44.1"},{"groupId":"OG001","value":"35.5","lowerLimit":"30.5","upperLimit":"40.8"}]}]},{"title":"Any unsolicited AE, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"336"},{"groupId":"OG001","value":"342"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"30.7","lowerLimit":"25.8","upperLimit":"35.9"},{"groupId":"OG001","value":"32.2","lowerLimit":"27.2","upperLimit":"37.4"}]}]}]},{"type":"SECONDARY","title":"Percentage of Infants With Unsolicited AEs","description":"An unsolicited AE was any AE that was not solicited using a subject diary and that was spontaneously communicated by the subject. Also any 'solicited' symptom with onset outside the specified period of follow-up for solicited symptoms was reported as an unsolicited adverse event.","populationDescription":"The analysis was done on the TVC of Mother, which included all subjects with the study vaccine administration documented and who had returned their diary cards.","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Percentage of subjects","timeFrame":"From delivery to Month 2 post delivery (Visit 4, end of the study).","groups":[{"id":"OG000","title":"dTpa Group - Infant","description":"This group consisted of infants born to mothers (from dTpa Group Mother) who received a dose of Boostrix during pregnancy."},{"id":"OG001","title":"Control Group - Infnat","description":"This group consisted of infants born to mothers (from Control Group Mother) who received a dose of placebo during pregnancy."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"341"},{"groupId":"OG001","value":"346"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"26.4","lowerLimit":"21.8","upperLimit":"31.4"},{"groupId":"OG001","value":"22.3","lowerLimit":"18.0","upperLimit":"27.0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Serious AEs (SAEs)","description":"A SAE was any untoward medical occurrence that resulted in death, was life threatening, required hospitalization or prolongation of hospitalization, resulted in disability/incapacity or a congenital anomaly/birth defect in the offspring of a study subject.","populationDescription":"The analysis was done on the TVC, which included all subjects with the study vaccine administration documented.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Day 0 (Visit 1) to Month 2 (Visit 4, end of the study).","groups":[{"id":"OG000","title":"dTpa Group - Mother","description":"This group consisted of pregnant women who received a single dose of Boostrix at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of the placebo post-delivery (within 72 hours)."},{"id":"OG001","title":"Control Group - Mother","description":"This group consisted of pregnant women who received a single dose of placebo at 27-36 weeks (i.e. 27 weeks until 36 completed weeks) of gestation (Visit 1) and received a dose of Boostrix post-delivery (within 72 hours)."},{"id":"OG002","title":"dTpa Group - Infant","description":"This group consisted of infants born to mothers (from dTpa Group Mother) who received a dose of Boostrix during pregnancy."},{"id":"OG003","title":"Control Group - Infant","description":"This group consisted of infants born to mothers (from Control Group Mother) who received a dose of placebo during pregnancy"},{"id":"OG004","title":"Household Group","description":"This group consisted of eligible household contacts of the infants born to pregnant women enrolled in Spain who received a single dose of Boostrix anytime during the study."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"341"},{"groupId":"OG001","value":"346"},{"groupId":"OG002","value":"341"},{"groupId":"OG003","value":"346"},{"groupId":"OG004","value":"608"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"51"},{"groupId":"OG001","value":"52"},{"groupId":"OG002","value":"52"},{"groupId":"OG003","value":"45"},{"groupId":"OG004","value":"0"}]}]}]},{"type":"SECONDARY","title":"Percentage of Household Contacts of the Infants Born to Pregnant Women Vaccinated in Spain","description":"This analysis assessed the vaccination status of the household contacts (who accepted, received or refused vaccination) and also the reasons for refusal (not coming to site, refused to be vaccinated, unspecified) as part of an assessment of cocooning among the eligible household contacts.","populationDescription":"This analysis was done on the Total cohort for household contacts in Spain, which included all eligible household contacts of the infants born to pregnant women vaccinated in Spain.","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"Percentage of household contacts","timeFrame":"From Day 0 (Visit 1) to Month 2 (Visit 4, end of the study).","groups":[{"id":"OG000","title":"Household Group","description":"This group consisted of eligible household contacts of the infants born to pregnant women enrolled in Spain who received a single dose of Boostrix anytime during the study."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"723"}]}],"classes":[{"title":"Accepted vaccination","categories":[{"measurements":[{"groupId":"OG000","value":"84.4","lowerLimit":"81.5","upperLimit":"86.9"}]}]},{"title":"Received vaccination","categories":[{"measurements":[{"groupId":"OG000","value":"84.1","lowerLimit":"81.2","upperLimit":"86.7"}]}]},{"title":"Refused vaccination","categories":[{"measurements":[{"groupId":"OG000","value":"15.6","lowerLimit":"13.1","upperLimit":"18.5"}]}]},{"title":"Not coming to site","categories":[{"measurements":[{"groupId":"OG000","value":"1.4","lowerLimit":"0.7","upperLimit":"2.5"}]}]},{"title":"Refused to be vaccinated","categories":[{"measurements":[{"groupId":"OG000","value":"13.4","lowerLimit":"11","upperLimit":"16.1"}]}]},{"title":"Unspecified","categories":[{"measurements":[{"groupId":"OG000","value":"0.8","lowerLimit":"0.3","upperLimit":"1.8"}]}]}]},{"type":"SECONDARY","title":"Percentage of Household Contacts With SAEs","description":"SAEs assessed include medical occurrences that results in death, are life threatening, require hospitalization or prolongation of hospitalization, results in disability/incapacity or are a congenital anomaly/birth defect in the offspring of a study subjects.","populationDescription":"This analysis was done on the Total cohort for household contacts which included all eligible household contacts of the infants born to pregnant women vaccinated in Spain. For the analysis of safety, all vaccinated household contacts are considered.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Percentage of subjects","timeFrame":"During the 31-day (Days 0-30) follow-up period post-vaccination (Boostrix administered preferably 2 weeks before the birth of the infant, Visit 3).","groups":[{"id":"OG000","title":"Household Group","description":"This group consisted of eligible household contacts of the infants born to pregnant women enrolled in Spain who received a single dose of Boostrix anytime during the study."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"723"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"0","timeFrame":"For the Mothers' Groups: Solicited local and general AEs were reported during Days 0 - 7 following each dose. Unsolicited AEs were reported during Days 0 - 30 following each dose. SAEs were reported during the entire study period (Day 0 up to Month 2). For the Infants' Groups: unsolicited AEs and SAEs were reported From Day 0 (Visit 1) to Month 2 (Visit 4, end of the study). For the Household Group: SAEs were reported during the 31-day (Days 0-30) follow-up period post-vaccination.","description":"No solicited symptoms were assessed for the Infants' Groups and Household Group.","eventGroups":[{"id":"EG000","title":"dTpa Group-Mother","description":"This group consisted of pregnant women who received a single dose of Boostrix at 27-36 weeks (i.e. completed 27 weeks until 36 weeks) of gestation (Visit 1) and received a dose of the placebo post-delivery (within 72 hours).","deathsNumAffected":0,"deathsNumAtRisk":341,"seriousNumAffected":51,"seriousNumAtRisk":341,"otherNumAffected":321,"otherNumAtRisk":341},{"id":"EG001","title":"Control Group-Mother","description":"This group consisted of pregnant women who received a single dose of placebo at 27-36 weeks (i.e. completed 27 weeks until 36 weeks) of gestation (Visit 1) and received a dose of Boostrix post-delivery (within 72 hours).","deathsNumAffected":0,"deathsNumAtRisk":346,"seriousNumAffected":52,"seriousNumAtRisk":346,"otherNumAffected":303,"otherNumAtRisk":346},{"id":"EG002","title":"dTpa Group - Infant","description":"This group consisted of infants born to mothers (from dTpa Group Mother) who received a dose of Boostrix during pregnancy.","deathsNumAffected":0,"deathsNumAtRisk":341,"seriousNumAffected":52,"seriousNumAtRisk":341,"otherNumAffected":33,"otherNumAtRisk":341},{"id":"EG003","title":"Control Group-Infant","description":"This group consisted of infants born to mothers (from Control Group Mother) who received a dose of placebo during pregnancy","deathsNumAffected":0,"deathsNumAtRisk":346,"seriousNumAffected":45,"seriousNumAtRisk":346,"otherNumAffected":29,"otherNumAtRisk":346},{"id":"EG004","title":"Household Group","description":"This group consisted of eligible household contacts of the infants born to pregnant women enrolled in Spain who received a single dose of Boostrix anytime during the study.","deathsNumAffected":0,"deathsNumAtRisk":608,"seriousNumAffected":0,"seriousNumAtRisk":608,"otherNumAffected":0,"otherNumAtRisk":608}],"seriousEvents":[{"term":"Anaemia neonatal","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Isoimmune haemolytic disease","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Atrioventricular block complete","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Supraventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Atrial septal defect","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Cardiac septal defect","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Congenital cardiovascular anomaly","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Congenital hydronephrosis","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Cryptorchism","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":3,"numAffected":3,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Hypospadias","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Microtia","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Polydactyly","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Pyloric stenosis","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Syndactyly","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Transposition of the great vessels","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Trisomy 21","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Ventricular septal defect","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Gastrooesophageal reflux disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Hyperbilirubinaemia","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":3,"numAffected":3,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Hyperbilirubinaemia neonatal","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Jaundice","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":8,"numAffected":8,"numAtRisk":341},{"groupId":"EG003","numEvents":6,"numAffected":6,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Amniotic cavity infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Beta haemolytic streptococcal infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Bronchiolitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":3,"numAffected":3,"numAtRisk":341},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Endometritis decidual","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Enterovirus infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Influenza","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Mastitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Nasopharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Neonatal infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Perineal infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Respiratory syncytial virus bronchiolitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Sepsis neonatal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Superinfection bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Tracheitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Fall","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Procedural haemorrhage","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Cardiac murmur","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Dehydration","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Hypernatraemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Hypocalcaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Hypoglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Hypoglycaemia neonatal","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Neonatal hypocalcaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Hypotonia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Somnolence neonatal","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Cephalhaematoma","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Foetal distress syndrome","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Foetal growth restriction","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Gestational hypertension","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":341},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Hellp syndrome","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Jaundice neonatal","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Large for dates baby","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Placenta praevia haemorrhage","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Polyhydramnios","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Postpartum haemorrhage","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":341},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Pre-eclampsia","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Premature baby","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":11,"numAffected":11,"numAtRisk":341},{"groupId":"EG003","numEvents":9,"numAffected":9,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Premature delivery","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":341},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Premature labour","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":11,"numAtRisk":341},{"groupId":"EG001","numEvents":11,"numAffected":11,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Premature rupture of membranes","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":13,"numAffected":13,"numAtRisk":341},{"groupId":"EG001","numEvents":17,"numAffected":17,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Preterm premature rupture of membranes","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":341},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Retained placenta or membranes","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Small for dates baby","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":3,"numAffected":3,"numAtRisk":341},{"groupId":"EG003","numEvents":3,"numAffected":3,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Threatened labour","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Uterine contractions during pregnancy","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Acute kidney injury","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Hydronephrosis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Vesicoureteric reflux","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Female genital tract fistula","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Metrorrhagia","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Uterine atony","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Uterine haemorrhage","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Vaginal haemorrhage","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Apnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Asphyxia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Meconium aspiration syndrome","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Neonatal asphyxia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Neonatal respiratory depression","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Pneumothorax","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Pulmonary embolism","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Respiratory distress","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":5,"numAffected":5,"numAtRisk":341},{"groupId":"EG003","numEvents":4,"numAffected":4,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Transient tachypnoea of the newborn","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Rash neonatal","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Deep vein thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]}],"otherEvents":[{"term":"Abdominal discomfort","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":4,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":9,"numAffected":9,"numAtRisk":341},{"groupId":"EG003","numEvents":6,"numAffected":6,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Abdominal pain lower","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Abdominal pain upper","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Affect lability","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Afterbirth pain","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":17,"numAffected":17,"numAtRisk":341},{"groupId":"EG001","numEvents":20,"numAffected":20,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Alopecia areata","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Amniotic cavity infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":11,"numAffected":11,"numAtRisk":341},{"groupId":"EG001","numEvents":14,"numAffected":14,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Anaemia of pregnancy","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":341},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Anogenital warts","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Aphonia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Asthenia","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Axillary pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":11,"numAffected":11,"numAtRisk":341},{"groupId":"EG001","numEvents":14,"numAffected":13,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Blood pressure increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Bradycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Breast engorgement","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Breast inflammation","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Breast mass","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Breast pain","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Bronchiolitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Cephalhaematoma","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Cervical dilatation","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Cervical discharge","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Chills","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Cholestasis of pregnancy","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Clavicle fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Conjunctival haemorrhage","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Conjunctivitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":346},{"groupId":"EG002","numEvents":8,"numAffected":7,"numAtRisk":341},{"groupId":"EG003","numEvents":3,"numAffected":3,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":341},{"groupId":"EG001","numEvents":10,"numAffected":10,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":341},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Cow's milk intolerance","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Cystitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Dacryostenosis acquired","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Deafness","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Depression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Dermatitis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG002","numEvents":4,"numAffected":4,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Dermatitis contact","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Discomfort","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Dislocation of vertebra","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":7,"numAtRisk":341},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Dyspepsia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":341},{"groupId":"EG001","numEvents":5,"numAffected":4,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Dysuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Ear pain","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Eczema eyelids","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Endometritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Epistaxis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Erythema","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Extrapyramidal disorder","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":276,"numAffected":188,"numAtRisk":341},{"groupId":"EG001","numEvents":277,"numAffected":186,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Flank pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Flatulence","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Fluid retention","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Foreign body","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Fungal infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Fungal skin infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Gastritis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Gastroenteritis viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Gastrointestinal disorder","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":92,"numAffected":78,"numAtRisk":341},{"groupId":"EG001","numEvents":95,"numAffected":83,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Gastrooesophageal reflux disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":341},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Genital herpes","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Genital infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Genital infection fungal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Granuloma","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Groin abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Grunting","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Haemorrhoids","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":341},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":169,"numAffected":129,"numAtRisk":341},{"groupId":"EG001","numEvents":169,"numAffected":126,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Heart rate decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Herpes simplex","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Hordeolum","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Hot flush","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Hyperbilirubinaemia","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Hyperhidrosis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Hypothermia","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Hypothyroidism","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Impaired healing","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Incision site pain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Influenza","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Influenza like illness","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Ingrowing nail","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Inguinal hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Injection site bruising","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Injection site erythema","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":130,"numAffected":106,"numAtRisk":341},{"groupId":"EG001","numEvents":142,"numAffected":117,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Injection site haematoma","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Injection site induration","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Injection site mass","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Injection site pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":330,"numAffected":290,"numAtRisk":341},{"groupId":"EG001","numEvents":258,"numAffected":223,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Injection site pruritus","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Injection site rash","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Injection site reaction","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Injection site swelling","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":101,"numAffected":91,"numAtRisk":341},{"groupId":"EG001","numEvents":99,"numAffected":92,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Injection site urticaria","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Insomnia","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Iron deficiency","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Irritability","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Jaundice","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG003","numEvents":5,"numAffected":5,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Joint injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Labour pain","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Laceration","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Ligament pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Ligament sprain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Limb discomfort","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Malaise","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Mastitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":341},{"groupId":"EG001","numEvents":14,"numAffected":14,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Mastitis postpartum","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Melanocytic naevus","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Menorrhagia","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Metrorrhagia","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Migraine","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Migraine with aura","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Milk allergy","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Muscle haemorrhage","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Musculoskeletal stiffness","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":341},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Nasal congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":341},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Nasal obstruction","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Nasopharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":341},{"groupId":"EG001","numEvents":12,"numAffected":12,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Neck pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Night sweats","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Nipple disorder","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Nipple infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Nipple inflammation","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Nipple pain","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Nodule","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Oligohydramnios","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Oral candidiasis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Oral herpes","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Oropharyngeal pain","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":13,"numAffected":13,"numAtRisk":341},{"groupId":"EG001","numEvents":13,"numAffected":13,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Otitis media acute","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Ovarian cyst torsion","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Paraesthesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Paralysis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Pelvic pain","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Perineal pain","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Periodontitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Peripheral swelling","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Pharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Phlebitis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Post procedural haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Post procedural inflammation","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Postoperative abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Postoperative wound infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Procedural haemorrhage","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Procedural headache","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Procedural pain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Pruritus","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Pruritus generalised","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Pruritus genital","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Pyelocaliectasis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Pyelonephritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":20,"numAffected":20,"numAtRisk":341},{"groupId":"EG001","numEvents":33,"numAffected":32,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Rash","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Raynaud's phenomenon","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Renal colic","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Respiratory distress","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Respiratory tract infection viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Restless legs syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Rhinitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Rhinitis allergic","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Rhinorrhoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Sciatica","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Seasonal allergy","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Sinus congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Small for dates baby","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Somnolence","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Stomatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Suppressed lactation","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Supraventricular extrasystoles","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Suture related complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Suture rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Swelling","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Throat irritation","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Thyroid dysfunction in pregnancy","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Tinea pedis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Toothache","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Transient tachypnoea of the newborn","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Traumatic delivery","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Umbilical hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":11,"numAtRisk":341},{"groupId":"EG001","numEvents":13,"numAffected":13,"numAtRisk":346},{"groupId":"EG002","numEvents":3,"numAffected":3,"numAtRisk":341},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Upper-airway cough syndrome","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Urethral prolapse","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":341},{"groupId":"EG001","numEvents":11,"numAffected":10,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Urticaria","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Uterine contractions during pregnancy","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Uterine hypotonus","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Uterine irritability","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Uterine pain","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Uterine prolapse","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Vaccination site pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Vaginal discharge","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Vaginal infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Varicose vein","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Varicose veins vulval","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Vessel puncture site bruise","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Vulvovaginal candidiasis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Vulvovaginal mycotic infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Vulvovaginal pain","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]},{"term":"Wound dehiscence","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":341},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":346},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":341},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":346},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":608}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial."},"pointOfContact":{"title":"GSK Response Center","organization":"GlaxoSmithKline","email":"en736091@gsk.com","phone":"866-435-7343"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot","hasProtocol":true,"hasSap":false,"hasIcf":false,"label":"Study Protocol","date":"2015-07-15","uploadDate":"2018-08-10T06:14","filename":"Prot_000.pdf","size":1648491},{"typeAbbrev":"SAP","hasProtocol":false,"hasSap":true,"hasIcf":false,"label":"Statistical Analysis Plan","date":"2018-02-20","uploadDate":"2018-08-10T06:16","filename":"SAP_001.pdf","size":1628660}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-11-09"},"interventionBrowseModule":{"meshes":[{"id":"C505143","term":"Boostrix"}]}},"hasResults":true}